Leveraging co-crystallization to enhance therapeutic potential of anti-cancer drugs
Abstract
Pharmaceutical co-crystals incorporating a minimum of one active pharmaceutical ingredient (API) remain a significant area of interest for investigators, particularly in the field of anti-cancer drugs. Co-crystals are formed via the non-covalent association of two or more distinct drug molecules. Co-crystallization is a process that can significantly improve several physicochemical characteristics, such as bioactivity, stability, solubility, and compressibility. This review focuses on co-crystals containing anti-cancer drugs reported in the literature, examining their physicochemical properties like permeability, solubility, stability, dissolution, bioavailability, and antitumor efficacy compared to the parent compounds. Although few publications specifically address the impact of anti-cancer co-crystals on drug resistance, there is a critical need for ongoing research in this area. The rising issue of drug resistance in cancer treatment underscores the importance of leveraging co-crystal technology to develop more effective therapeutic options. This review highlights, categorizes, and compares existing studies on anti-cancer drug co-crystals and encourages future research to explore their potential in overcoming drug resistance.
Keywords:
Co-crystallization, anti-cancer drugs, crystal engineering, pharmaceutical co-crystals, combination therapyDOI
https://doi.org/10.25004/References
Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12-49. Available from: https://doi.org/10.3322/caac.21820
Kaur J, Gulati M, Jha NK, Disouza J, Patravale V, Dua K, et al. Recent advances in developing polymeric micelles for treating cancer: Breakthroughs and bottlenecks in their clinical translation. Drug Discovery Today. 2022;27(5):1495-512. Available from: https://doi.org/10.1016/j.drudis.2022.02.005
Arpicco S, Dosio F, Stella B, Cattel L. Anticancer Prodrugs: An Overview of Major Strategies and Recent Developments. Current Topics in Medicinal Chemistry. 2011;11(18):2346-81. Available from: https://doi.org/10.2174/156802611797183221
Bolla G, Nangia A. Pharmaceutical cocrystals: walking the talk. Chemical Communications. 2016;52(54):8342-60. Available from: https://doi.org/10.1039/C6CC02943D
Aakeröy CB, Forbes S, Desper J. Using Cocrystals to Systematically Modulate Aqueous Solubility and Melting Behavior of an Anticancer Drug. Journal of the American Chemical Society 2009;131(47):17048-9. Available from: https://doi.org/10.1021/ja907674c
Vishweshwar P, McMahon JA, Bis JA, Zaworotko MJ. Pharmaceutical co-crystals. Journal of Pharmaceutical Sciences. 2006;95(3):499-516. Available from: https://doi.org/10.1002/jps.20578
Duggirala NK, Perry ML, Almarsson Ö, Zaworotko MJ. Pharmaceutical cocrystals: along the path to improved medicines. Chemical Communications. 2016;52(4):640-55. Available from: https://doi.org/10.1039/C5CC08216A
Fábián L. Cambridge Structural Database Analysis of Molecular Complementarity in Cocrystals. Crystal Growth & Design. 2009;9(3):1436-43. Available from: https://doi.org/10.1021/cg800861m
Thipparaboina R, Kumar D, Chavan RB, Shastri NR. Multidrug co-crystals: towards the development of effective therapeutic hybrids. Drug Discovery Today. 2016;21(3):481-90. Available from: https://doi.org/10.1016/j.drudis.2016.02.001
Gala UH, Miller DA, Williams RO. Harnessing the therapeutic potential of anticancer drugs through amorphous solid dispersions. Biochimica et Biophysica Acta Reviews on Cancer. 2020;1873(1):188319. Available from: https://doi.org/10.1016/j.bbcan.2019.188319
Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods. 2000;44(1):235-49. Available from: https://doi.org/10.1016/S1056-8719(00)00107-6
Bohr A, Nascimento TL, Harmankaya N, Weisser JJ, Wang Y, Grohganz H, et al. Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy. Molecules. 2019;24(2):266. Available from: https://doi.org/10.3390/molecules24020266
Szczurek J, Rams-Baron M, Knapik-Kowalczuk J, Antosik A, Szafraniec J, Jamróz W, et al. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures. Molecular Pharmaceutics. 2017;14(4):1071-81. Available from: https://doi.org/10.1021/acs.molpharmaceut.6b01080
Savjani KT, Gajjar AK, Savjani JK. Drug Solubility: Importance and Enhancement Techniques. ISRN Pharmaceutics. 2012; 2012:1-10. Available from: https://doi.org/10.5402/2012/195727
Yadav A, Shete A, Dabke A, Kulkarni P, Sakhare S. Co-crystals: A novel approach to modify physicochemical properties of active pharmaceutical ingredients. Indian Journal of Pharmaceutical Sciences. 2009;71(4):359. Available from: https://doi.org/10.4103/0250-474X.57282
Lekhan A, Fiore C, Shemchuk O, Grepioni F, Braga D, Turner RJ. Comparison of Antimicrobial and Antibiofilm Activity of Proflavine Co-crystallized with Silver, Copper, Zinc, and Gallium Salts. ACS Applied Bio Materials. 2022;5(9):4203-12. Available from: https://doi.org/10.1021/acsabm.2c00835
Jubeen F, Liaqat A, Sultan M, Zafar Iqbal S, Sajid I, Sher F. Green synthesis and biological evaluation of novel 5-fluorouracil derivatives as potent anticancer agents. Saudi Pharmaceutical Journal. 2019;27(8):1164-73. Available from: https://doi.org/10.1016/j.jsps.2019.08.001
Cuadra IA, Cabañas A, Cheda JAR, Türk M, Pando C. Cocrystallization of the anticancer drug 5-fluorouracil and coformers urea, thiourea or pyrazinamide using supercritical CO2 as an antisolvent (SAS) and as a solvent (CSS). The Journal of Supercritical Fluids. 2020;160:104813. Available from: https://doi.org/10.1016/j.supflu.2020.104813
Jubeen F, Liaqat A, Amjad F, Sultan M, Iqbal SZ, Sajid I, et al. Synthesis of 5-Fluorouracil Cocrystals with Novel Organic Acids as Coformers and Anticancer Evaluation against HCT-116 Colorectal Cell Lines. Crystal Growth & Design. 2020;20(4):2406-14. Available from: https://pubs.acs.org/doi/abs/10.1021/acs.cgd.9b01570
Yu YM, Liu L, Bu FZ, Li YT, Yan CW, Wu ZY. A novice cocrystal nanomicelle formulation of 5-fluorouracil with proline: The design, self-assembly and in vitro/vivo biopharmaceutical characteristics. International Journal of Pharmaceutics. 2022;617:121635. Available from: https://doi.org/10.1016/j.ijpharm.2022.121635
Heinen T, Hoelscher S, Vasylyeva V. Structural study of anhydrous and hydrated 5-fluorouracil co-crystals with nicotinamide and isonicotinamide. Zeitschrift für Kristallographie Crystalline Materials.2022;237(4-5):109-16. Available from: https://www.degruyter.com/document/doi/10.1515/zkri-2021-2052/html
Gautam MK, Besan M, Pandit D, Mandal S, Chadha R. Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters. AAPS Pharm SciTech. 2019;20(4):1-17. Available from: https://link.springer.com/article/10.1208/s12249-019-1360-9
Yu YM, Niu YY, Wang LY, Li YT, Wu ZY, Yan CW. Supramolecular self-assembly and perfected in vitro/vivo property of 5-fluorouracil and ferulic acid on the strength of double optimized strategy: the first 5-fluorouracial-phenolic acid nutraceutical cocrystal with synergistic antitumor efficacy. Analyst. 2021;146(8):2506-19. Available from: https://pubs.rsc.org/en/content/articlelanding/2021/an/d1an00171j
Yao J, Chen JM, Xu YB, Lu TB. Enhancing the solubility of 6-mercaptopurine by formation of ionic cocrystal with zinc trifluoromethanesulfonate: Single-crystal-to-single-crystal transformation. Crystal Growth & Design. 2014;14(10):5019-25. Available from: https://pubs.acs.org/doi/abs/10.1021/cg5005819pubs.acs
Xu LL, Chen JM, Yan Y, Lu TB. Improving the solubility of 6-mercaptopurine via cocrystals and salts. Crystal Growth & Design. 2012;12(12):6004-11. Available from: https://pubs.acs.org/doi/abs/10.1021/cg3010745pubs.acs
Yu YM, Yu MC, Wang LY, Li YT, Wu ZY, Yan CW. A supramolecular adduct of tegafur and syringic acid: the first tegafur-nutraceutical cocrystal with perfected in vitro and in vivo characteristics as well as synergized anticancer activities. New Journal of Chemistry. 2020;44(37):15994-6005. Available from: https://pubs.rsc.org/en/content/articlehtml/2020/nj/d0nj03033c
Mei H, Wang N, Wu D, Rong Q, Bai X, Huang X, et al. Novel Pharmaceutical Cocrystals of Tegafur: Synthesis, Performance, and Theoretical Studies. Pharmaceutical Research. 2024;41(3):577-93. Available from: https://link.springer.com/article/10.1007/s11095-024-03668-4
Ren BY, Dai XL, Wang J, Wu C, Lu TB, Chen JM. Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior. Cryst Eng Comm. 2021;23(32):5504-15. Available from: https://pubs.rsc.org/en/content/articlehtml/2021/ce/d1ce00620g
Ren BY, Dai XL, Chen JM, Lu TB. Two anhydrous forms and one monohydrate of a cocrystal of axitinib and glutaric acid: characterization, property evaluation and phase transition study. Cryst Eng Comm. 2022;24(11):2138-48. Available from: https://pubs.rsc.org/en/content/articlehtml/2022/ce/d1ce01740c
Rai SK, Gunnam A, Mannava MKC, Nangia AK. Improving the Dissolution Rate of the Anticancer Drug Dabrafenib. Crystal Growth & Design. 2020;20(2):1035-46. Available from: https://pubs.acs.org/doi/abs/10.1021/acs.cgd.9b01365
Chiodo THAHTSBSMBFSBVM. Multicomponent Crystals Comprising Dasatinib and Selected Cocrystal Formers. International patent PCT/IB2013/054832, 2017.
Abdul Azeeze MST, Kandasamy S, Palanisamy P, Palanichamy P, Subramania Nainar M. Cocrystallization of Dasatinib with different acids improves the solubility and physicochemical properties: A combined experimental and theoretical studies. Chemical Physics Impact. 2023;7:100247. Available from: https://doi.org/10.1016/j.cple.2023.100247
Pandit D, Chadha R, Laha B, Gautam MK, Karan M, Mandal SK. Novel Pharmaceutical Cocrystals of Gefitinib: A Credible Upswing in Strategic Research to Ameliorate Its Biopharmaceutical Challenges. Crystal Growth & Design. 2022;22(4):2218-29. Available from: https://pubs.acs.org/doi/abs/10.1021/acs.cgd.1c01328
Pi J, Wang S, Li W, Kebebe D, Zhang Y, Zhang B, et al. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein. Asian Journal of Pharmaceutical Sciences. 2019;14(2):154-64. Available from: https://doi.org/10.1016/j.ajps.2018.06.004
Nicolov M, Ghiulai RM, Voicu M, Mioc M, Duse AO, Roman R, et al. Cocrystal formation of betulinic acid and ascorbic acid: Synthesis, physico-chemical assessment, antioxidant, and antiproliferative activity. Frontiers in Chemistry 2019;7:435425. Available from: https://www.frontiersin.org/articles/10.3389/fchem.2019.00435/full
Paulazzi AR, Alves BO, Zilli GAL, dos Santos AE, Petry F, Soares KD, et al. Curcumin and n-acetylcysteine cocrystal produced with supercritical solvent: characterization, solubility, and preclinical evaluation of antinociceptive and anti-inflammatory activities. Inflammopharmacology. 2022;30(1):327-41. Available from: https://link.springer.com/article/10.1007/s10787-021-00917-5
Sathisaran I, Devidas Bhatia D, Vishvanath Dalvi S. New curcumin-trimesic acid cocrystal and anti-invasion activity of curcumin multicomponent solids against 3D tumor models. International Journal of Pharmaceutics. 2020;587:119667. Available from: https://doi.org/10.1016/j.ijpharm.2020.119667
Pantwalawalkar J, More H, Bhange D, Patil U, Jadhav N. Novel curcumin ascorbic acid cocrystal for improved solubility. Journal of Drug Delivery Science and Technology. 2021;61:102233. Available from: https://doi.org/10.1016/j.jddst.2020.102233
Ribas MM, Sakata GSB, Santos AE, Dal Magro C, Aguiar GPS, Lanza M, et al. Curcumin cocrystals using supercritical fluid technology. The Journal of Supercritical Fluids. 2019;152:104564. Available from: https://doi.org/10.1016/j.supflu.2019.04.024
Babu NJ, Sanphui P, Nangia A. Crystal Engineering of Stable Temozolomide Cocrystals. Chemistry - An Asian Journal. 2012;7(10):2274-85. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/asia.201200205
Fan X, Chen J, Shen Q. Docetaxel–nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. International Journal of Pharmaceutics 2013;458(2):296-304. Available from: https://doi.org/10.1016/j.ijpharm.2013.10.049
Song JX, Yan Y, Yao J, Chen JM, Lu TB. Improving the solubility of lenalidomide via cocrystals. Crystal Growth & Design. 2014;14(6):3069-77. Available from: https://pubs.acs.org/doi/abs/10.1021/cg500327s
Song JX, Chen JM, Lu TB. Lenalidomide-gallic acid cocrystals with constant high solubility. Crystal Growth & Design. 2015;15(10):4869-75. Available from: https://pubs.acs.org/doi/abs/10.1021/acs.cgd.5b00699
Reggane M, Wiest J, Saedtler M, Harlacher C, Gutmann M, Zottnick SH, et al. Bioinspired co-crystals of Imatinib providing enhanced kinetic solubility. European Journal of Pharmaceutics and Biopharmaceutics. 2018;128:290-9. Available from: https://doi.org/10.1016/j.ejpb.2018.05.016
Shi X, Wang C, Chen Q, Shen S, Song S, Zhou X. Improving physicochemical properties of Ibrutinib with cocrystal strategy based on structures and natures of the carboxylic acid co-formers. Journal of Drug Delivery Sciences and Technology. 2021;63:102554. Available from: https://doi.org/10.1016/j.jddst.2021.102554
Hong M, Li S, Ji W, Qi MH, Ren G Bin. Cocrystals of lenvatinib with sulfamerazine and salicylic acid: Crystal structure, equilibrium solubility, stability study, and anti-hepatoma activity. Crystal Growth & Design. 2021;21(7):3714-27. Available from: https://pubs.acs.org/doi/abs/10.1021/acs.cgd.1c00022
Duan C, Liu W, Tao Y, Liang F, Chen Y, Xiao X, et al. Two novel palbociclib-resorcinol and palbociclib-orcinol cocrystals with enhanced solubility and dissolution rate. Pharmaceutics. 2022;14(1):23. Available from: https://www.mdpi.com/1999-4923/14/1/23/htm
Jia JL, Dai XL, Che HJ, Li MT, Zhuang XM, Lu TB, et al. Cocrystals of regorafenib with dicarboxylic acids: synthesis, characterization and property evaluation. Cryst Eng Comm. 2021;23(3):653-62. Available from: https://pubs.rsc.org/en/content/articlehtml/2021/ce/d0ce01341b
Shahbaz M, Khan UA, Iqbal Chaudhary M, Yousuf S. A new bioactive cocrystal of coumarin-3-carboxylic acid and thiourea: detailed structural features and biological activity studies. Acta Crystallographica section C Structural Chemistry. 2022;78(3):192-200. Available from: https://journals.iucr.org/paper?ov3156
Ban E, An SH, Park B, Park M, Yoon NE, Jung BH, et al. Improved Solubility and Oral Absorption of Emodin-Nicotinamide Cocrystal Over Emodin with PVP as a Solubility Enhancer and Crystallization Inhibitor. Journal of Pharmaceutical Sciences. 2020;109(12):3660-7. Available from: http://jpharmsci.org/article/S0022354920305608/fulltext
Liu C, Liu Z, Chen Y, Chen Z, Chen H, Pui Y, et al. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion. European Journal of Pharmaceutics and Biopharmaceutics. 2018;124:73-81. Available from: https://doi.org/10.1016/j.ejpb.2017.12.003
Luo Y, Chen S, Zhou J, Chen J, Tian L, Gao W, et al. Luteolin cocrystals: Characterization, evaluation of solubility, oral bioavailability and theoretical calculation. Journal of Drug Delivery Sciences and Technology. 2019;50:248-54. Available from: https://doi.org/10.1016/j.jddst.2018.12.018
Pessoa AS, Aguiar GPS, Vladimir Oliveira J, Bortoluzzi AJ, Paulino A, Lanza M. Precipitation of resveratrol-isoniazid and resveratrol-nicotinamide cocrystals by gas antisolvent. The Journal of Supercritical Fluids. 2019;145:93-102. Available from: https://doi.org/10.1016/j.supflu.2018.12.012
Hisada N, Takano R, Takata N, Shiraki K, Ueto T, Tanida S, et al. Characterizing the dissolution profiles of supersaturable salts, cocrystals, and solvates to enhance in vivo oral absorption. European Journal of Pharmaceutics and Biopharmaceutics 2016;103:192-9. Available from: https://doi.org/10.1016/j.ejpb.2016.03.012
Published
Abstract Display: 13 How to Cite
Issue
Section
Copyright (c) 2026 Prashant Kumar, Kaushal Kumar
This work is licensed under a Creative Commons Attribution 4.0 International License.
